Current
5.9×
5-Year Average
4.8×
All-Time High
6.4×
All-Time Low
2.3×
P/S Ratio daily chart for Johnson & Johnson (JNJ)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Johnson & Johnson (JNJ) from 2001 to 2025
| 2025 | $504.08B | $94.19B | 5.4× | +1.5× | |
| 2024 | $345.01B | $88.82B | 3.9× | -0.5× | |
| 2023 | $377.30B | $85.16B | 4.4× | -0.6× | |
| 2022 | $461.69B | $91.15B | 5.1× | +0.3× | |
| 2021 | $449.74B | $93.78B | 4.8× | -0.2× | |
| 2020 | $414.30B | $82.58B | 5.0× | +0.3× | |
| 2019 | $384.00B | $82.06B | 4.7× | +0.4× | |
| 2018 | $351.53B | $81.58B | 4.3× | -0.6× | |
| 2017 | $375.13B | $76.45B | 4.9× | +0.6× | |
| 2016 | $311.82B | $71.89B | 4.3× | +0.3× | |
| 2015 | $283.01B | $70.07B | 4.0× | +0.1× | |
| 2014 | $291.04B | $74.33B | 3.9× | +0.3× | |
| 2013 | $258.34B | $71.31B | 3.6× | +0.7× | |
| 2012 | $194.77B | $67.22B | 2.9× | +0.1× | |
| 2011 | $178.94B | $65.03B | 2.8× | -0.0× | |
| 2010 | $169.65B | $61.59B | 2.8× | -0.1× | |
| 2009 | $177.64B | $61.90B | 2.9× | +0.3× | |
| 2008 | $165.99B | $63.75B | 2.6× | -0.5× | |
| 2007 | $190.47B | $61.09B | 3.1× | -0.5× | |
| 2006 | $192.28B | $53.32B | 3.6× | +0.1× | |
| 2005 | $179.39B | $50.51B | 3.6× | -0.4× | |
| 2004 | $188.24B | $47.35B | 4.0× | +0.3× | |
| 2003 | $153.33B | $41.86B | 3.7× | -0.7× | |
| 2002 | $159.73B | $36.30B | 4.4× | -1.1× | |
| 2001 | $179.37B | $32.49B | 5.5× | — |
- 20255.4×
- 20243.9×
- 20234.4×
- 20225.1×
- 20214.8×
- 20205.0×
- 20194.7×
- 20184.3×
- 20174.9×
- 20164.3×
- 20154.0×
- 20143.9×
- 20133.6×
- 20122.9×
- 20112.8×
- 20102.8×
- 20092.9×
- 20082.6×
- 20073.1×
- 20063.6×
- 20053.6×
- 20044.0×
- 20033.7×
- 20024.4×
- 20015.5×
About P/S Ratio at Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) P/S ratio is 5.9× as of June 5, 2026. The 5-year average is 4.8×. The sector median currently stands at 3.5×. The current ratio is at the 95th percentile of its own 10-year history.
Johnson & Johnson (JNJ) historical P/S ratio has ranged from a low of 2.3× (2009) to a high of 6.4× (2026) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Johnson & Johnson P/S Ratio by Year
Johnson & Johnson P/S Ratio 2025: 5.4×
Johnson & Johnson (JNJ) P/S ratio in 2025 was 5.4×, expanded from 3.9× the prior year.
Johnson & Johnson P/S Ratio 2024: 3.9×
Johnson & Johnson (JNJ) P/S ratio in 2024 was 3.9×, contracted from 4.4× the prior year.
Johnson & Johnson P/S Ratio 2023: 4.4×
Johnson & Johnson (JNJ) P/S ratio in 2023 was 4.4×, contracted from 5.1× the prior year.
Johnson & Johnson P/S Ratio 2022: 5.1×
Johnson & Johnson (JNJ) P/S ratio in 2022 was 5.1×, expanded from 4.8× the prior year.
Johnson & Johnson P/S Ratio 2021: 4.8×
Johnson & Johnson (JNJ) P/S ratio in 2021 was 4.8×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Johnson & Johnson (JNJ), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric